Providing Evidence to Support New Product Introductions in Nursing With Colleen O’Leary, DNP, RN, AOCNS®, EBP-C

At this year’s Oncology Nursing Society (ONS) Annual Congress, Oncology Data Advisor sat down with Colleen O’Leary, DNP, RN, AOCNS®, EBP-C, Associate Director of Evidence-Based Practice at the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute in Westerville, Ohio. Dr. O’Leary discusses her poster “Stop the Madness: Decreasing the Number of New Product Trials Based on Evidence.”

In this interview, Dr. O’Leary goes in-depth about:

  • The overwhelming number of new products from vendors and manufactures that are constantly introduced into the clinical setting
  • Confusion surrounding which products are viable and should be implemented into practice
  • The development of a nursing value analysis team (VAT) to review new product requests
  • Compiling evidence on new product trials to support their use
  • How this approach has helped nurses understand which products are the best based on real-world evidence

And more!

About Dr. O’Leary

Colleen O’Leary, DNP, RN, AOCNS®, EBP-C, Associate Director of Evidence-Based Practice at the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute in Westerville, Ohio. She has over 30 years of oncology nursing experience and has led numerous projects focused on evidence-based practice. In her current position, Dr. O’Leary works as a consultant and facilitates educational courses focused on evidence-based practice in nursing.

Related Articles

Responses

Your email address will not be published. Required fields are marked *